Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.65 -0.05 (-7.76%)
At close: Oct 23, 2026 · 4:00 PM EDT

Milestone Pharmaceuticals (MIST) Amortization of Deferred Charges (2023 - 2026)

Updated

Analysis

Milestone Pharmaceuticals (MIST) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Milestone Pharmaceuticals 89.86 Mn -80.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 118,000.00
Mar 31, 2026 117,000.00
Dec 31, 2025 115,000.00
Sep 30, 2025 109,000.00
Jun 30, 2025 106,000.00
Mar 31, 2025 102,000.00
Dec 31, 2024 97,000.00
Sep 30, 2024 95,000.00
Jun 30, 2024 91,000.00
Mar 31, 2024 87,000.00
Dec 31, 2023 84,000.00
Sep 30, 2023 80,000.00
API Access

Milestone Pharmaceuticals Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=MIST&period=max&api_key=YOUR_API_KEY